Abstract
Twenty novel N-diarylalkenyl-piperidinecarboxylic acid derivatives were synthesized and evaluated as gamma-aminobutyric acid uptake inhibitors. The biological assay showed that (R)-1-[4,4-bis(3-phenoxymethyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic hydrochloride possessed almost as strong GAT1 inhibitory activity as tiagabine. The synthesis and structure-activity relationships are discussed.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Biological Transport
-
Carboxylic Acids / chemical synthesis
-
Carboxylic Acids / chemistry*
-
Chemistry, Pharmaceutical / methods
-
Drug Design
-
Drug Evaluation, Preclinical
-
GABA Agonists / chemistry
-
GABA Agonists / pharmacology*
-
Humans
-
Inhibitory Concentration 50
-
Models, Chemical
-
Neurons / metabolism
-
Nipecotic Acids / chemistry
-
Nipecotic Acids / pharmacology
-
Pipecolic Acids / chemical synthesis
-
Pipecolic Acids / chemistry*
-
Structure-Activity Relationship
-
Tiagabine
-
gamma-Aminobutyric Acid / metabolism*
-
gamma-Aminobutyric Acid / pharmacokinetics
Substances
-
Carboxylic Acids
-
GABA Agonists
-
Nipecotic Acids
-
Pipecolic Acids
-
gamma-Aminobutyric Acid
-
Tiagabine